X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (51883) 51883
Book Review (4574) 4574
Newsletter (2841) 2841
Publication (1913) 1913
Conference Proceeding (151) 151
Magazine Article (87) 87
Book Chapter (45) 45
Dissertation (43) 43
Newspaper Article (38) 38
Reference (6) 6
Book / eBook (5) 5
Web Resource (4) 4
Trade Publication Article (3) 3
Government Document (2) 2
Presentation (2) 2
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44019) 44019
humans (40198) 40198
female (25905) 25905
male (21701) 21701
middle aged (21550) 21550
fluorouracil - administration & dosage (21327) 21327
oncology (19875) 19875
fluorouracil (19285) 19285
aged (18698) 18698
antineoplastic combined chemotherapy protocols - therapeutic use (16814) 16814
adult (15597) 15597
chemotherapy (13842) 13842
cancer (12250) 12250
fluorouracil - therapeutic use (10874) 10874
5-fluorouracil (8776) 8776
treatment outcome (8242) 8242
animals (7585) 7585
fluorouracil - adverse effects (6289) 6289
fluorouracil - pharmacology (6049) 6049
combined modality therapy (6000) 6000
colorectal cancer (5994) 5994
antineoplastic combined chemotherapy protocols - adverse effects (5965) 5965
colorectal neoplasms - drug therapy (5748) 5748
cisplatin - administration & dosage (5596) 5596
research (5225) 5225
care and treatment (5168) 5168
neoplasm staging (5126) 5126
leucovorin (5004) 5004
prognosis (4987) 4987
breast neoplasms - drug therapy (4914) 4914
aged, 80 and over (4913) 4913
surgery (4901) 4901
leucovorin - administration & dosage (4724) 4724
carcinoma (4719) 4719
antineoplastic combined chemotherapy protocols - administration & dosage (4524) 4524
chemotherapy, adjuvant (4519) 4519
drug administration schedule (4404) 4404
mice (4384) 4384
deoxycytidine - analogs & derivatives (4356) 4356
adenocarcinoma - drug therapy (4229) 4229
survival rate (4173) 4173
capecitabine (4157) 4157
therapy (4149) 4149
colorectal neoplasms - pathology (4134) 4134
fluorouracil - analogs & derivatives (4054) 4054
disease-free survival (3996) 3996
oxaliplatin (3957) 3957
pharmacology & pharmacy (3812) 3812
retrospective studies (3772) 3772
cisplatin (3651) 3651
survival (3622) 3622
antineoplastic agents - therapeutic use (3585) 3585
abridged index medicus (3573) 3573
radiotherapy (3409) 3409
survival analysis (3392) 3392
follow-up studies (3295) 3295
neoplasm metastasis (3199) 3199
metastasis (3174) 3174
stomach neoplasms - drug therapy (3164) 3164
organoplatinum compounds - administration & dosage (3122) 3122
analysis (3118) 3118
liver neoplasms - secondary (3109) 3109
time factors (3068) 3068
antimetabolites, antineoplastic - therapeutic use (3042) 3042
medicine & public health (3030) 3030
camptothecin - analogs & derivatives (3003) 3003
liver neoplasms - drug therapy (2995) 2995
trial (2979) 2979
cyclophosphamide - administration & dosage (2973) 2973
colonic neoplasms - drug therapy (2844) 2844
deoxycytidine - administration & dosage (2819) 2819
antimetabolites, antineoplastic - administration & dosage (2799) 2799
carcinoma, squamous cell - drug therapy (2557) 2557
cell line, tumor (2488) 2488
antineoplastic agents - administration & dosage (2466) 2466
methotrexate - administration & dosage (2424) 2424
dose-response relationship, drug (2420) 2420
irinotecan (2409) 2409
prospective studies (2401) 2401
breast cancer (2375) 2375
drug therapy, combination (2350) 2350
doxorubicin - administration & dosage (2294) 2294
health aspects (2248) 2248
drug therapy (2247) 2247
oncology, experimental (2247) 2247
colorectal-cancer (2232) 2232
tumors (2227) 2227
breast neoplasms - pathology (2221) 2221
camptothecin - administration & dosage (2116) 2116
bevacizumab (2064) 2064
apoptosis (2054) 2054
lymphatic metastasis (2018) 2018
colon cancer (1988) 1988
infusions, intravenous (1988) 1988
1st-line treatment (1970) 1970
adenocarcinoma - pathology (1959) 1959
adenocarcinoma (1913) 1913
antineoplastic agents - pharmacology (1904) 1904
gastroenterology & hepatology (1896) 1896
adjuvant chemotherapy (1873) 1873
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (47140) 47140
Japanese (3376) 3376
German (1075) 1075
French (971) 971
Chinese (779) 779
Russian (615) 615
Italian (291) 291
Spanish (209) 209
Polish (101) 101
Korean (77) 77
Portuguese (54) 54
Hungarian (42) 42
Dutch (31) 31
Danish (29) 29
Czech (28) 28
Hebrew (22) 22
Norwegian (21) 21
Ukrainian (14) 14
Romanian (13) 13
Swedish (13) 13
Turkish (12) 12
Slovak (11) 11
Bulgarian (10) 10
Croatian (6) 6
Serbian (6) 6
Finnish (5) 5
Lithuanian (5) 5
Afrikaans (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmaceutical Research, ISSN 0724-8741, 05/2015, Volume 32, Issue 5, p. 1585
We optimize the encapsulation and investigate the pharmacokinetics of 5-Fluorouracil (5-FU) delivered by thermosensitive stealth.sup.[R] liposomes (TSLs)... 
Fluorouracil
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 11/2013, Volume 69, p. 508
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 12/2013, Volume 58, Issue 12, p. 3440
Although 5-fluorouracil (5-FU) is a widely used as chemotherapy agent, severe mucositis develops in approximately 80 % of patients. 5-FU-induced small... 
Fluorouracil
Journal Article
The Journal of Supercritical Fluids, ISSN 0896-8446, 08/2013, Volume 80, p. 1
Journal Article
JDDG, ISSN 1610-0379, 05/2015, Volume 13, Issue 5, p. 430
  Zusammenfassung Hintergrund Der Anteil der in Deutschland diagnostizierten und dermatologisch behandelten aktinischen Keratosen (AK) ist in den letzten... 
Fluorouracil
Journal Article
Acta Medica Colombiana, ISSN 0120-2448, 10/2015, Volume 40, Issue 4, p. 338
La neurotoxicidad de los medicamentos antineoplasicos es un fenomeno de relativa frecuencia, que ocurre principalmente sobre el sistema nervioso periferico y... 
Fluorouracil
Journal Article
Der Onkologe, ISSN 0947-8965, 01/2013, Volume 19, Issue 1, p. 64
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article
Prescriber, ISSN 0959-6682, 05/2014, Volume 25, Issue 10, pp. 33 - 33
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1843 - 1852
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINES | OXALIPLATIN | III NONINFERIORITY | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis | Index Medicus
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2015, Volume 87, p. S72
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 02/2016, Volume 137, p. 9
* HP-[beta]-CD inclusion and thermo-reversible techniques were applied in combination. * 5FU-HP-[sz]-CD complex increased drug solubility and facilitated drug... 
Cyclodextrins | Fluorouracil
Journal Article
Clinical cancer research, ISSN 1078-0432, 2011, Volume 17, Issue 10, pp. 3455 - 3468
To explore the effect of dihydropyrimidine dehydrogenase (DPD) single nucleotide polymorphisms (SNP) and haplotypes on outcome of capecitabine. Germline DNA... 
IVS14+1G-GREATER-THAN-A MUTATION | 1ST-LINE TREATMENT | MULTICENTER RANDOMIZED-TRIAL | POINT MUTATION | ONCOLOGY | DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY | FLUOROURACIL PLUS LEUCOVORIN | PHASE-III | SPLICE DONOR SITE | DPD DEFICIENCY | SEVERE 5-FLUOROURACIL TOXICITY | Haplotypes | Capecitabine | Colorectal Neoplasms - genetics | Humans | Middle Aged | Polymorphism, Single Nucleotide - physiology | Male | Case-Control Studies | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Clinical Trials, Phase III as Topic | Deoxycytidine - therapeutic use | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - genetics | Aged, 80 and over | Adult | Deoxycytidine - adverse effects | Female | Retrospective Studies | Carcinoma - drug therapy | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Treatment Outcome | Disease Progression | Randomized Controlled Trials as Topic | Antimetabolites, Antineoplastic - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Carcinoma - genetics | Aged | Biomarkers, Tumor - genetics | Biomarkers, Pharmacological - metabolism | Dihydrouracil Dehydrogenase (NADP) - metabolism | Deoxycytidine - analogs & derivatives | Dihydrouracil Dehydrogenase (NADP) - genetics | Cohort Studies | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5513 - 5518
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2008, Volume 358, Issue 1, pp. 36 - 46
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3191 - 3198
Journal Article